Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

CJC-1295 DAC 2 mg: research material

Buy CJC-1295 DAC 2 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

The supplied CJC-1295 DAC is identified by CAS 446262-90-4. It is a modified growth hormone-releasing hormone (GHRH) analogue. Its DAC modification allows association with serum albumin, a protein in blood.

Choose the material and presentation

The DAC designation is part of the material identity. A listing labeled CJC-1295 NO DAC refers to a different construct; matching only the CJC name or vial size is not enough. Check which form the experimental method specifies before choosing a product.

Other presentations: CJC-1295 DAC 5 mg.

Why the DAC modification matters

Jetté and colleagues compared modified human growth hormone-releasing factor constructs in rat pituitary-cell assays and rat experiments. Their CJC-1295 construct included a reactive group attached through an added lysine. Albumin conjugation and resistance to enzymatic breakdown were central to the study.

Those observations concern a defined molecular construct in experimental conditions. They cannot assign the same behavior to NO DAC material or establish the shelf life of a dry vial.

Original study

Product records and batch reports

Open the COA and documents tab for the available batch reports and product files. Match the product and lot, then read identity, purity and measured content as separate results.

Additional information

CAS No.

446262-90-4

Purity

≥99%

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Applications

Growth hormone secretion studies, lean mass research, aging research

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

COA & Documents

Independent lot testing

CJC-1295 DAC 2mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
13878
Report number
COA261057-026
Date tested
August 11, 2026
Reported purity
99.6%
Labeled content
2 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for CJC-1295 DAC 2mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support